Media & Announcements

Beacon Pharma sets up dedicated antibiotic plant for Tk 250cr

Beacon Pharmaceuticals inaugurated a new facility today to manufacture antibiotics exclusively -- a venture that is likely to fetch the company Tk 100 crore in export receipts a year. Health Minister Zahid Malik will inaugurate the plant through video conferencing on August 20. The plant, which sits on 3 acres of land in Bhaluka upazila [...]

By |2020-09-28T03:31:14+00:00August 23rd, 2020|Media & Announcements|0 Comments

News links On Effectiveness on Favipiravir through “Dhaka Trial”

Dhaka Tribune Link: Daily Star Link : The Daily New Nation : Daily Sun : Observer : Our Time: The Business Standard :

By |2020-07-22T04:59:29+00:00July 22nd, 2020|Media & Announcements|0 Comments

Favipira of Beacon Pharma 96pc effective in clinical trial

Effective results have been found in the clinical trials of Beacon Pharmaceuticals 'Favipiravir' for the treatment of coronavirus infected patients.The Bangladesh Society of Medicine (BSM) conducted the trial in the capital where 96 per cent of the patients recovered from Covid-19.The result of the clinical trial was announced by Prof Syed Golam Mogni Mawla, an [...]

By |2020-09-28T03:31:15+00:00July 16th, 2020|Media & Announcements|0 Comments

Beacon Pharma Favipiravir

Beacon Pharma, a generic drugmaker from Bangladesh, will start clinical trials to see if the anti-viral drug Favipiravir is a safe option to treat Covid-19. In an interview to ET, Monjulrul Alam, Director, Beacon Pharma, said that the company is looking at the safety profile of the drug compared with HCQ that is being widely [...]

By |2020-09-28T03:31:15+00:00July 16th, 2020|Media & Announcements|0 Comments

Trial finds Favipira effective for treating mild, moderate Covid-19 patients

96% of the patients who participated in the clinical trial were cured by the anti-flu drug, according to medical professionals involved with the trial A limited-scale clinical trial has found Favipira, an antiviral drug to treat influenza, to be effective in treating patients with mild to moderate Covid-19 symptoms. Around 96% patients who participated in [...]

By |2020-07-16T06:34:05+00:00July 16th, 2020|Media & Announcements|0 Comments

Covid-19 Patients: Favipiravir effective in Dhaka trial

The Bangladesh Society of Medicine (BSM) has found effectiveness of Favipiravir as a clinically proven drug for the treatment of Covid-19 patient. After ending trial in Wuhan province of China and Russia, the Dhaka trial revealed similar effectiveness of Favipiravir in treating Covid-19 infected patients. The BSM found around 96 percent patients to be Covid-19 [...]

By |2020-07-16T06:31:18+00:00July 16th, 2020|Media & Announcements|0 Comments

Commercial production starts of another promising COVID-19 cure

Local pharmaceuticals have started commercial production of an anti-flu and viral infection medication found effective in treating novel coronavirus patients by Combined Military Hospital (CMH) and Bangladesh Air Force (BAF). Favipiravir was originally developed to treat influenza by Toyama Chemical, which was owned by Fujifilm, the Japanese photography company that now has sizable holdings in [...]

By |2020-09-28T03:31:15+00:00July 14th, 2020|Media & Announcements|0 Comments

Beacon produces antiviral drug Favipiravir to fight Covid-19

Beacon Pharmaceuticals Limited has developed an antiviral drug Favipiravir, better known as Avigan, accelerating treatment for the people infected with the novel coronavirus (Covid-19). In 2014, Fujifilm Toyama Chemical Company invented the drug first in Japan and the drug was used in treating the people who were infected with Ebola virus, said a press release [...]

By |2020-07-22T05:17:22+00:00July 12th, 2020|Media & Announcements|0 Comments

Beacon Pharmaceuticals Ltd. achieve First Prize in 23rd National Annual Quality Convention 2019

23rd National Annual Quality Convention 2019 was held on 16 March,2019 at BIAM Foundation, New Eskaton, Dhaka organized by Bangladesh Society for Total Quality Management (BSTQM). The theme of the program was  “Developing people for better tomorrow. “Seventy-four (74) teams from different organizations around the country participated in the competition. The “Most Innovative [...]

By |2020-09-28T03:31:16+00:00September 23rd, 2019|Media & Announcements|0 Comments

Beacon Point rewarded as the best Rehab Center from Department of Narcotics Control

                          Beacon Point received first prize for its service excellence for treatment and Rehabilitation of addicted patients for last two consecutive years by the Department of Narcotics Control (DNC). Chief Adviser of Beacon Group, Mr. Khandoker Rashidul Huq received the award on behalf [...]

By |2020-09-28T03:31:16+00:00September 22nd, 2019|Media & Announcements|0 Comments

Beacon Organized a Seminar on Cancer Survivors.

Beacon organized a seminar on “imanix and Dasanix Survivors: Extending & Enhancing Life” to celebrate the life of Cancer survivors. About 50 survivors attended the seminar who are using these drugs for 3-10 years. The main objectives of the seminar were to deliver the message that it is possible to diagnose at least 7 signs [...]

By |2020-09-28T03:31:16+00:00September 22nd, 2019|Media & Announcements|0 Comments

BEACON held Annual Conference in Cox’s Bazar

The “Annual Sales Conference 2016” of BEACON Pharmaceuticals Limited (BPL) was held in Cox’s Bazar on 18th December 2016. The daylong conference was inaugurated by welcome speech of BEACON’S Managing Director, Md. Ebadul Karim. BEACON has started its journey in 2006 with the vision to become a global company. In 10 years of time BEACON [...]

By |2020-09-28T03:31:18+00:00January 16th, 2017|Media & Announcements|0 Comments

Beacon signs €10m deal with Macofer, Italy for fully automated Injectable line

Romaco Macofer, Italy, a supplier of equipment and technology to a range of process industries, has confirmed a €10m deal with Bangladesh-based company, Beacon Pharmaceuticals Limited (BPL), a manufacturer of branded generic products for the Asia, Africa, and Latin America. Under the terms of the contract, Macofer will deliver a fully automated injectable filling and [...]

By |2020-09-28T03:31:19+00:00April 3rd, 2016|Media & Announcements|Comments Off on Beacon signs €10m deal with Macofer, Italy for fully automated Injectable line